MAPT and Alzheimer disease: Firstly, current treatments targeting either the Aβ-related pathway or Tau protein hyperphosphorylation have not achieved the desired success, possibly due to the fact that neither the Aβ hypothesis nor the Tau hypothesis alone can fully explain the origin and development of AD.